Loading data for PLRX — first visit, this takes a few seconds.
Pliant Therapeutics Inc. (PLRX)
NasdaqGS: PLRX
· 실시간 가격 · USD
1.10
+0.03 (2.80%)
종가 기준: Aug 19, 2026, 3:58 PM
1.10
+0.00%
애프터마켓: 7:30 PM
Pliant Therapeutics Inc. (PLRX) Stock Price, Analysis & Data
2.80% (1D)
PLRX 소개
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integr...
전체 기업 정보재무 실적
2025년 Pliant Therapeutics의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -149.34M로, -28.99% 감소했습니다.
재무제표
